Review:
Radioimmunotherapy
overall review score: 4.2
⭐⭐⭐⭐⭐
score is between 0 and 5
Radioimmunotherapy is a targeted cancer treatment that combines radiation therapy with immunotherapy by using monoclonal antibodies labeled with radioactive isotopes. This approach allows for precise delivery of radiation directly to cancer cells, minimizing damage to surrounding healthy tissue and enhancing the body's immune response against tumors.
Key Features
- Targets specific cancer cell markers using monoclonal antibodies
- Delivers localized radiation dose to tumor sites
- Reduces systemic side effects compared to traditional radiotherapy
- Uses radioactive isotopes such as Iodine-131 or Yttrium-90
- Applicable to certain hematologic malignancies and solid tumors
Pros
- Highly targeted treatment minimizes damage to healthy tissue
- Effective for certain types of cancers, especially hematologic malignancies
- Can be used in cases resistant to conventional therapies
- Potentially fewer side effects than traditional radiation exposure
Cons
- Limited availability and high cost of treatment
- Risk of radiation-related side effects, such as marrow suppression
- Not suitable for all cancer types or all patients
- Requires careful handling and specialized facilities